HSD67 Real-World Initiation of Recombinant Zoster Vaccine in U.S. Adults 51 Years or Older: A Commercial Claims Analysis
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.1374
https://www.valueinhealthjournal.com/article/S1098-3015(23)01474-2/fulltext
Title :
HSD67 Real-World Initiation of Recombinant Zoster Vaccine in U.S. Adults 51 Years or Older: A Commercial Claims Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01474-2&doi=10.1016/j.jval.2023.03.1374
First page :
Section Title :
Open access? :
No
Section Order :
10783